These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26238079)

  • 1. Fluorescent CSC models evidence that targeted nanomedicines improve treatment sensitivity of breast and colon cancer stem cells.
    Gener P; Gouveia LP; Sabat GR; de Sousa Rafael DF; Fort NB; Arranja A; Fernández Y; Prieto RM; Ortega JS; Arango D; Abasolo I; Videira M; Schwartz S
    Nanomedicine; 2015 Nov; 11(8):1883-92. PubMed ID: 26238079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Andrographolide-loaded PLGA-PEG-PLGA micelles to improve its bioavailability and anticancer efficacy.
    Zhang J; Li Y; Gao W; Repka MA; Wang Y; Chen M
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1367-80. PubMed ID: 24935153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel double-targeted nondrug delivery system for targeting cancer stem cells.
    Qiao S; Zhao Y; Geng S; Li Y; Hou X; Liu Y; Lin FH; Yao L; Tian W
    Int J Nanomedicine; 2016; 11():6667-6678. PubMed ID: 27994463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Breast Cancer Stem Cells Using a Newly Developed Long-acting Fluorescence Probe, C5S-A, Targeting ALDH1A1.
    Okamoto A; Funakoshi Y; Oe M; Takai R; Suto H; Nagatani Y; Nishimura M; Imamura Y; Kunihisa T; Kiyota N; Miki K; Ohe K; Tanino H; Minami H
    Anticancer Res; 2022 Mar; 42(3):1199-1205. PubMed ID: 35220209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles.
    Zhang Y; Zhang H; Wang X; Wang J; Zhang X; Zhang Q
    Biomaterials; 2012 Jan; 33(2):679-91. PubMed ID: 22019123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functionalized nanospheres for targeted delivery of paclitaxel.
    Bushman J; Vaughan A; Sheihet L; Zhang Z; Costache M; Kohn J
    J Control Release; 2013 Nov; 171(3):315-21. PubMed ID: 23792807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR-targeted poly(ethylene glycol)-distearoylphosphatidylethanolamine micelle loaded with paclitaxel for laryngeal cancer: preparation, characterization and in vitro evaluation.
    Ren H; Gao C; Zhou L; Liu M; Xie C; Lu W
    Drug Deliv; 2015; 22(6):785-94. PubMed ID: 24670093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of α-conotoxin ImI to actualize the targeted delivery of paclitaxel micelles to α7 nAChR-overexpressing breast cancer.
    Mei D; Lin Z; Fu J; He B; Gao W; Ma L; Dai W; Zhang H; Wang X; Wang J; Zhang X; Lu W; Zhou D; Zhang Q
    Biomaterials; 2015 Feb; 42():52-65. PubMed ID: 25542793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(ethylene glycol)-block-poly(d,l-lactic acid) micelles containing oligo(lactic acid)
    Tam YT; Shin DH; Chen KE; Kwon GS
    J Control Release; 2019 Mar; 298():186-193. PubMed ID: 30790593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic RGDyK conjugation facilitates intracellular drug delivery of polymeric micelles to integrin-overexpressing tumor cells and neovasculature.
    Yin J; Li Z; Yang T; Wang J; Zhang X; Zhang Q
    J Drug Target; 2011 Jan; 19(1):25-36. PubMed ID: 20233083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle.
    Rezazadeh M; Emami J; Hasanzadeh F; Sadeghi H; Minaiyan M; Mostafavi A; Rostami M; Lavasanifar A
    Drug Deliv; 2016 Jun; 23(5):1707-17. PubMed ID: 25188785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visualization and enrichment of live putative cancer stem cell populations following p53 inactivation or Bax deletion using non-toxic fluorescent dyes.
    Allen JE; Hart LS; Dicker DT; Wang W; El-Deiry WS
    Cancer Biol Ther; 2009 Nov; 8(22):2194-205. PubMed ID: 19923899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo evaluation of APRPG-modified angiogenic vessel targeting micelles for anticancer therapy.
    Guo P; Song S; Li Z; Tian Y; Zheng J; Yang X; Pan W
    Int J Pharm; 2015; 486(1-2):356-66. PubMed ID: 25840274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells.
    Ke XY; Lin Ng VW; Gao SJ; Tong YW; Hedrick JL; Yang YY
    Biomaterials; 2014 Jan; 35(3):1096-108. PubMed ID: 24183698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of novel biodegradable nanoparticles for the drug targeting to breast cancer cells.
    Mattu C; Pabari RM; Boffito M; Sartori S; Ciardelli G; Ramtoola Z
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):463-72. PubMed ID: 23916461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy.
    Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y
    Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines.
    Muraro MG; Mele V; Däster S; Han J; Heberer M; Cesare Spagnoli G; Iezzi G
    Stem Cells Transl Med; 2012 Aug; 1(8):592-603. PubMed ID: 23197865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "OA02" peptide facilitates the precise targeting of paclitaxel-loaded micellar nanoparticles to ovarian cancer in vivo.
    Xiao K; Li Y; Lee JS; Gonik AM; Dong T; Fung G; Sanchez E; Xing L; Cheng HR; Luo J; Lam KS
    Cancer Res; 2012 Apr; 72(8):2100-10. PubMed ID: 22396491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin E-Oligo(methyl diglycol l-glutamate) as a Biocompatible and Functional Surfactant for Facile Preparation of Active Tumor-Targeting PLGA Nanoparticles.
    Wu J; Zhang J; Deng C; Meng F; Zhong Z
    Biomacromolecules; 2016 Jul; 17(7):2367-74. PubMed ID: 27305935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fmoc-conjugated PEG-vitamin E2 micelles for tumor-targeted delivery of paclitaxel: enhanced drug-carrier interaction and loading capacity.
    Zhang Y; Huang Y; Zhao W; Lu J; Zhang P; Zhang X; Li J; Gao X; Venkataramanan R; Li S
    AAPS J; 2014 Nov; 16(6):1282-91. PubMed ID: 25193267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.